LHC Group (LHCG) vs. Chemed (CHE) Head to Head Survey

LHC Group (NASDAQ: LHCG) and Chemed (NYSE:CHE) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their valuation, profitability, risk, institutional ownership, analyst recommendations, earnings and dividends.

Insider and Institutional Ownership

How to Become a New Pot Stock Millionaire

89.9% of LHC Group shares are held by institutional investors. Comparatively, 94.8% of Chemed shares are held by institutional investors. 14.8% of LHC Group shares are held by company insiders. Comparatively, 4.9% of Chemed shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Dividends

Chemed pays an annual dividend of $1.12 per share and has a dividend yield of 0.4%. LHC Group does not pay a dividend. Chemed pays out 20.9% of its earnings in the form of a dividend. Chemed has increased its dividend for 9 consecutive years.

Earnings & Valuation

This table compares LHC Group and Chemed’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
LHC Group $1.07 billion 1.22 $50.11 million $2.42 29.47
Chemed $1.67 billion 2.67 $98.17 million $5.36 51.28

Chemed has higher revenue and earnings than LHC Group. LHC Group is trading at a lower price-to-earnings ratio than Chemed, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

LHC Group has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500. Comparatively, Chemed has a beta of 1.06, indicating that its stock price is 6% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings and price targets for LHC Group and Chemed, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LHC Group 0 1 9 0 2.90
Chemed 0 2 1 0 2.33

LHC Group presently has a consensus price target of $77.56, indicating a potential upside of 8.76%. Chemed has a consensus price target of $266.50, indicating a potential downside of 3.05%. Given LHC Group’s stronger consensus rating and higher probable upside, research analysts plainly believe LHC Group is more favorable than Chemed.

Profitability

This table compares LHC Group and Chemed’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
LHC Group 4.67% 9.18% 5.94%
Chemed 5.89% 30.04% 16.40%

Summary

Chemed beats LHC Group on 12 of the 17 factors compared between the two stocks.

About LHC Group

LHC Group, Inc. is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services. Through its home health services segment, the Company offers a range of services, including skilled nursing, medically oriented social services, and physical, occupational and speech therapy. Through its hospice services segment, the Company offers a range of services, including pain and symptom management, and emotional and spiritual support. Its community-based service operations offer a range of services to patients in their home or in a medical facility. The services range from assistance with grooming, medication reminders and meal preparation. It provides facility-based services principally through its LTACHs.

About Chemed

Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Zacks: MAM Software Group  Given $8.50 Consensus Target Price by Analysts
Zacks: MAM Software Group Given $8.50 Consensus Target Price by Analysts
Advanced Disposal  Receives Consensus Rating of “Hold” from Analysts
Advanced Disposal Receives Consensus Rating of “Hold” from Analysts
Herc Holdings Inc.  Receives Average Recommendation of “Hold” from Analysts
Herc Holdings Inc. Receives Average Recommendation of “Hold” from Analysts
Freshpet  vs. General Mills  Head to Head Analysis
Freshpet vs. General Mills Head to Head Analysis
Critical Survey: Qurate Retail Group  versus Its Peers
Critical Survey: Qurate Retail Group versus Its Peers
Financial Survey: Telia  versus Its Rivals
Financial Survey: Telia versus Its Rivals


© 2006-2018 Ticker Report. Google+.